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Epigenetics of asthma and allergic disease is a field that has expanded greatly in the last decade. Previously
thought only in terms of cell differentiation, it is now evident the epigenetics regulate many processes. With T cell
activation, commitment toward an allergic phenotype is tightly regulated by DNA methylation and histone
modifications at the Th2 locus control region. When normal epigenetic control is disturbed, either experimentally or
by environmental exposures, Th1/Th2 balance can be affected. Epigenetic marks are not only transferred to
daughter cells with cell replication but they can also be inherited through generations. In animal models, with
constant environmental pressure, epigenetically determined phenotypes are amplified through generations and can
last up to 2 generations after the environment is back to normal. In this review on the epigenetic regulation of
asthma and allergic diseases we review basic epigenetic mechanisms and discuss the epigenetic control of Th2
cells. We then cover the transgenerational inheritance model of epigenetic traits and discuss how this could relate
the amplification of asthma and allergic disease prevalence and severity through the last decades. Finally, we
discuss recent epigenetic association studies for allergic phenotypes and related environmental risk factors as well
as potential underlying mechanisms for these associations.
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Amplification hypothesisIntroduction
The term epigenetics was coined by C.H. Waddington in
the 1950’s to describe means in addition to genetics to ex-
plain cell differentiation [1]. The concept of epigenetics
was initially limited to cell differentiation from pluripotent
stem cells to unipotent well differentiated cells, but the
modern definition of epigenetics has been broaden beyond
differentiation to include non-sequence inheritance. Epi-
genetic mechanisms have been shown to regulate many
genes including those involved in inflammation and the
immune response and to ensure inheritance of phenotype
with cell division [2,3].
The purpose of this review is to provide allergy/immun-
ology professionals and researchers with a broad, yet easy-
to-follow, review of the epigenetic regulation of asthma
and allergic disease. The main focus will be on DNA
methylation and histone modifications, their relevance in
the process of allergic sensitization, their impact on* Correspondence: knadeau@stanford.edu
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article, unless otherwise stated.disease heritability and association with environmental ex-
posure and allergy phenotype. MicroRNA, which consti-
tute a distinct epigenetic mechanism, are beyond the
scope of this review. Their role in allergic disease has been
reviewed recently elsewhere [4].The basics
DNA methylation was the first epigenetic mechanism
recognised and the one that is most extensively studied.
De novo methylation occurs in response to various cel-
lular stressors and signal by DNA methyltransferases
(Dnmt3a and Dmnt3b) which add a methyl group to
position 5 of cytosine residues at a CpG site (Figure 1).
CpG sites are dinucleotides consisting of a cytosine and
guanine (the “p” stands for the phosphodiester bond
linking the 2 nucleotides) which occur throughout the
genome but may be concentrated in clusters referred to
as CpG islands found at important regulatory sites, such
as promoter and enhancer regions [5]. CpG islands are
defined as a region with 200 base pairs containing an
observed-to-expected CpG ratio that is greater than 60entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
Figure 1 Structure of methylcytosine and its by-products. 5-mC= 5’methylcytosine; 5-hmC = 5’-hydroxymethylcytosine; 5-fC = 5’-formylcytosine;
5-caC = 5’-carboxymethylcytosine.
Figure 2 Replication of methylated DNA. The palindromic nature
of CpG sites is key to their inheritance (A). With replication, each
separated strand carries one methylated cytosine (B). The daughter
hemi-methylated DNA (C) is recognised by DNMT isoform 1 which
methylates CpG sites on the new strand using the old one as a
template (D).
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ome CpG sites are methylated with most unmethylated
CpG islands found in functionally active genes [5].
The palindromic nature of a CpG site is important as it
ensures replication of the methylation pattern with each
cell division [5]. With DNA replication, both separated
strands of DNA will each carry one methylated cytosine to
be used as a template for duplication (Figure 2). The
resulting daughter DNA duplex strands will thus be
hemi-methylated. This hemi-methylated DNA is recog-
nized by a different DNA methyltransferase isoform
(Dnmt1) which methylates CpG sites on the new strand
using the old one as a template. This maintenance
methylation ensures conservation of the methylation
pattern during cell division.
Conversely, a CpG site can be demethylated by oxida-
tion of the methyl group. Physiologically, this process is
initiated by the enzyme Ten-eleven translocation (TET)
dioxygenase which gives rise to 5-hydroxymethylcytosine
and then to 5-formylcytosine and 5-carboxylcytosine [8].
These modified nucleic acids can also be generated, al-
though far less efficiently, by radical reactions involving
hydroxyl radical and one-electron oxidants. They are
then excised by the DNA repair enzyme thymine DNA
glycosylase and replaced by a normal cytosine [9].
The mechanism by which DNA methylation is associ-
ated with gene silencing is still not fully understood.
Earlier studies reported that methylation could directly
limit the access to transcription factors (TF) [10]. Al-
though this is true for some TF, it is not an absolute rule
as some TF have been shown to have greater specificity
for methylated binding motifs [11]. Methylated DNA
can also recruit methyl-CpG binding proteins which
compete with TF for access to binding sites [12]. Some
of these proteins, such as MeCP2, can further recruit
histone modifying enzymes to add another level of epi-
genetic modifications (discussed below) [13]. However,
the interaction between DNA methylation and other epi-
genetic mechanisms is not unidirectional as histone
modifications can also affect DNA methylation [14]. In
fact, studies in stem cells and thymocytes have shown
chromatin inactivation by histone and chromatin modi-
fying enzymes to precede de novo DNA methylation
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of its underlying mechanism, DNA methylation is import-
ant in itself and should not be viewed as an epiphenom-
enon of other epigenetic mechanism as DNMT mutants
display a multitude of defects, including aberrant gene ex-
pression, activation of mobile DNA elements and reduced
genome stability [18].
Chromatin, the complex of DNA and nucleic proteins in
the nucleus, is another central target of epigenetic mod-
ifications. Transcriptionally inactive heterochromatin is
packed densely whereas active euchromatin is less con-
densed (Figure 3). The core component of chromatin is
the histone octamer which organises DNA in structural
units called nucleosomes [18]. The histone octamer con-
sists of 2 dimers of core histones H2A and H2B and 2 di-
mers of core histones H3 and H4. Chromatin remodelling
is a fundamental mechanism for establishing somatic cell
memory of gene expression pattern. It is a dynamic process
which is regulated by histones and ATP-dependent chro-
matin remodeling complexes which either move, eject or
restructure nucleosomes. The "open" or "closed" state of
the chromatin near a particular gene can be revealed by
examining DNA sensitivity to the enzyme DNAse I by way
of a procedure known as a DNAse sensitivity assay. This
technique is based on the fact that DNAse I degrades open
DNA more quickly than closed DNA, hence the term
DNAse I hypersensitivity site (DHS) [19].
Core histones have long N-terminal tails protruding
from the nucleosome which can undergo posttranslational
modifications that alter their interaction with DNA and
nuclear proteins. The standard way of reporting thoseFigure 3 Euchromatin and heterochromatin. Unmethylated CpG islands
loose chromatin structure promote gene transcription in the euchromatin
modifications (red stars) and condensed structure prevent transcription in t
cooperativity and interaction between the different epigenetic modification
TET=Ten-eleven translocation dioxygenase; DNMT=DNA methyltransferase.modifications is by naming the histone, followed by the
amino acid, and the modification. For example, H3K4me1
would denote single methylation (me1) of lysine 4 (k4) on
histone 3 (H3). Research has shown a strong relation be-
tween covalent histone modifications and gene expression
[18]. As a general rule, histone acetylation or phosphoryl-
ation are associated with an active state. Histone methyla-
tion, on the other hand, appears to have diverse function
in the control of gene activity, depending on the amino
acid and the number of methyl- groups added. The nature
and combination of these changes determine the extent of
expression, with those highly expressed genes associated
with greater permissive histone modifications and those
less frequently transcribed ones associated with repressive
changes and more tightly packaged chromatin, although
the relationship between gene expression status and his-
tone modification is not absolute [20]. In addition to influ-
encing chromatin structure, recruitment of chromatin-
remodelling complexes by covalently modified amino acid
on histone tails may also help target gene locus for pre-
initiation of transcription gene [21,22]. The addition or re-
moval of the various chemical elements on histones is cat-
alyzed by histone modifying complexes such as histone
acetyl transferase (HAT) and histone deactetylase (HDAC)
which add and remove acetyl- groups on histone residues,
respectively.
Epigenetic control of T cell phenotype
Th2 differentiation
While epigenetic changes have been coined as the hall-
mark of cell differentiation, their importance in other(blank circles), permissive histone modifications (green stars) and
state. Conversely, DNA methylation (red circles), repressive histone
he heterochromatin state. Although governed by distinct enzymes,
s provide a self-reinforcing mechanism for epigenetic regulation.
Bégin and Nadeau Allergy, Asthma & Clinical Immunology 2014, 10:27 Page 4 of 12
http://www.aacijournal.com/content/10/1/27processes is now coming to light. Of note, T cell activation
and skewing, which could be viewed as a certain type of
cell differentiation, is governed in great parts by epigenetic
changes which insure that the clone of a T cell will retain
its phenotype (Th2, Th1 or otherwise) [23].
Th2 skewing is triggered by simultaneous TCR and
IL4 receptor activation, which leads to the phosphoryl-
ation of STAT6 and expression of Th2 master regulator
GATA-3 and Th2 signature cytokines, including IL-4.
Th1 differentiation is similarly triggered by simultaneous
TCR and IL-12 receptor activation, phosphorylation of
STAT4 and expression of Th1 master regulator TBET
and Th1 signature cytokine INF-γ, with silencing of Th2
cytokines.
In resting CD4 T cells, both IL-4 and IFN-g genes are
methylated [24]. Upon allergenic sensitization, the IL-4
promoter in allergen-specific T cells is demethylated, the
extent of which correlates with IL-4 expression [24]. The
IL-4 locus of Th2 cells is also marked with permissive
histone modifications H3K4me which are absent in Th1
or naïve T cells [25]. Similar modifications are found at
the IFN-γ locus in Th1 cells or the IL-17 locus in Th17
cells.
The main Th2 genes are positioned in the Th2 locus
control region (LCR) on chromosome 5 which forms a
chromatin hub that interacts with GATA-3 (Figure 4)
[23]. GATA-3 then interacts with HAT enzyme p300 and
with chromatin remodeling complex component Chd to
induce permissive histone and chromatin changes at the
Th2 LCR [26]. The GATA-3/Chd complex also binds
HDAC to repress the tbx21 locus encoding TBET, theFigure 4 Epigenetic control of the Th2 locus. Master regulator GATA-3 is
expression with a positive feedback mechanism. GATA-3 induces repressive h
p300 with chromatin remodeling complex component Chd to induce permis
epigenetic marks at the Th2 LCR [23] are presented in the lower box.master regulator of Th1 differentiation which activates
Th1 genes and suppresses Th2 genes [26], and recruits
the H3k27m3 methyltransferase EZH2 to the IFN-g
locus, causing its inhibition [27]. Further suppression of
Th1 cytokines is achieved by the increase of their DNA
methylation from naïve state [28]. In Th1 cells, STAT4
and TBET have been shown to exert similar but inverse
influence on IFN-g and Th2 genes epigenetics to pro-
mote Th1 skewing [29].
The exact mechanism of DNA demethylation of Th2
genes is still incompletely understood, possibly due to
the only recent discovery of the TET enzymes which are
responsible for physiological DNA demethylation. In a
mouse study, GATA-3 was insufficient to induce DNA
demethylation of the RAD50 DHS site 7 in the Th2
LCR, although the process was shown to be dependent
on STAT6 [30]. Interestingly, knocking-out RAD50 DHS
site 6 prevented DNA methylation of IL-4, IL-5 and IL-
13, suggesting an interdependence between those genes
and an important role for the chromatin hub structure
of the Th2 LCR (Figure 4) [31].
Interestingly, the GATA-3 promoter has been shown
to keep its repressive histone modification despite TH2
activation and present a bivalent state with both repressive
and activating histone modification [25]. This suggests
an important role for positive feedback to additionally
insure its stable expression, with GATA-3 positive bind-
ing to its regulatory elements. It is also worth noting
that the main anti-Th1 effect of GATA-3 is exerted
through direct inhibition of the IL-12/STAT4 and
RUNX pathways [23].induced by TCR and IL-4 receptor activation and maintains its own
istone modifications at Th1 loci (TBET, IFNG). It interacts with HAT enzyme
sive histone and chromatin changes at the Th2 LCR. Distribution of main
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T regulatory cells are a subset of T cells which suppress
the inflammatory response and thus play an important
role in immune tolerance to self and exogenous antigens.
Their function and number in tissue has been shown to
inversely correlate with allergic phenotypes and their im-
portance in allergic disease has been well described [32].
FOXP3 is the master regulator for regulatory T cells
(Treg) [33] which can be divided in two subsets based on
their origin: Tregs of thymic origin (tTreg), which were
previously referred to as natural Tregs and peripherally-
derived Treg (pTregs). FOXP3 expression is controlled by
proximal promoter and intronic regulatory elements des-
ignated as conserved non coding sequences (CNS1-3)
which are highly conserved between species.
In the thymus, tTregs are induced by TCR engagement
with self-peptide major histocompatibility complex with
specific strength and duration. The subsequent NF-κB sig-
naling induces permissive histone modification (H3K4me1)
at the CNS3 and potentially initiates chromatin remodeling
in the FOXP3 locus through the c-Rel subunit [34]. In
parallel, cAMP response element-binding protein (CREB)
binds to the CNS2 element, which inversely correlates
with the methylation status of CpG islands [35]. DNA de-
methylation of the CNS2, also called the Treg-specific
demethylated region (TSDR) is a major event in tTreg dif-
ferentiation and carries an important function in FOXP3
stabilizing FOXP3 expression [36]. CNS2 is the site at
which FOXP3 binds to its own gene to maintain expres-
sion in a positive feedback mechanism allowing for a
persistent phenotype and suppressive function. FOXP3
induces the expression of IL-2 receptor CD25, which acti-
vation phosphorylates STAT5 which binds the promoter
and CNS2 independently of methylation status providing
an additional positive feedback mechanism [37].
Besides Tregs, activated T cells also express FOXP3
upon TCR engagement [38]. However, this expression is
only transient as the CNS2 remains methylated. In fact,
when comparing tTregs to FOXP3+ activated effector T
cells there are hundreds of loci throughout the genome
which show demethylation and correspond to binding
sites for FOXP3 [39]. These methylation changes are not
induced by FOXP3 but rather allow FOXP3 to access its
targets and exert its function. The lack of demethylation
of these loci could explain the difference in function des-
pite the expression of FOXP3 in activated T cells.
In contrast to thymic-derived Tregs, generation of Tregs
from peripheral naïve T cells is favored by suboptimal
TCR stimulation in the presence of TGF-β [40]. TGF-β
promotes FOXP3 transcription in peripheral CD4 T cells
through binding of SMAD3 at CNS1 [41]. A FOXP3-
CNS1-deficient mice mouse has shown that CNS1 is crit-
ical for FOXP3 induction in peripheral CD4 T cells but
not in thymocytes. Interestingly, those mice lacked theself-reactive auto-immune manifestations observed in
FOXP3 deficient scrufy mice, but had maternal-fetal con-
flict and inflammatory disease at the mucosal interface,
suggesting a specific role for pTregs in acquired tolerance
to exogenous antigens [42]. The generation of TGF-β-in-
duced Tregs can be augmented by the addition of retinoic
acid, which has been shown to induce histone acetylation
at the CNS1 region [43]. While in vitro differentiated Treg
cells appear to lack TSDR demethylation, in vivo pTregs
gradually demethylate the TSDR which could contribute
to phenotype stability [44].Inheritance of epigenetic traits
Development of allergy and asthma is determined by
interplay between environmental and inherited factors,
the later accounting for over half of the risk [45]. Interest-
ingly, this is in high contrast with the low fraction of vari-
ance in asthma prevalence (4%) that can be accounted for
by genetic loci in a large-scale genome wide association
study [46,47]. This missing heritability could be due in
part to the difficulty of accounting for rare polymorphisms
with a high penetrance in some families (private muta-
tions) but it also raises the possibility of non-genetic
means of inheritance [46].
Genetics also fail to explain the sudden rise in allergies
and asthma as even with significant selection pressure,
any change in population genetics would necessitate mul-
tiple generations to occur. Epigenetic changes on the
other hand can be induced much more rapidly with vari-
ous environmental exposures and, like with genetics, these
changes can be passed down from parents to offspring.
There are several ways in which epigenetics can influence
phenotype inheritance, including gene imprinting, in utero
modifications and transgenerational inheritance.Parental imprinting and maternal influence
Asthma and atopy are complex genetic traits meaning
that the phenotype is the result of the interaction of
multiple genes each with their own Mendelian pattern
of inheritance. The expected result is that no clear pat-
tern of inheritance would be discernable, with risk from
both parents being very similar overall. In reality, the
risk for allergy and asthma inherited from the mother is
up to 5 fold greater than the paternal risk [48-51].
The discrepancy in parental risk could be explained in
part by parental imprinting. Parental imprinting is a
process by which some genes are epigenetically silenced
during gametogenesis in a parent-of-origin-specific man-
ner, which results in only one allele being expressed for
the imprinted loci. The best example probably consists
of polymorphisms of FcεR1-β which are only associated
with atopy when the risk allele is inherited from the
mother in multiple cohorts [49,52,53].
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ternal atopy predicted the expression profile of 18 cyto-
kines and chemokine in the airway mucosal fluid of
newborns [54]. However, it is unclear whether this is the
result of true genomic imprinting or from a direct modi-
fication of the foetal immune system by the mother’s
atopic phenotype in utero. Animal studies have shown
that challenging previously sensitized mice to ovalbumin
during pregnancy resulted in an increased allergic
phenotype in offsprings [55]. Transferring T cells from
sensitized to naïve pregnant mice had the same effect,
suggesting this in utero influence was mediated at least
in part by the maternal immune system after conception
[56]. In humans, one groups has evaluated the methy-
lome of over 300 pregnant women using a high through-
put DNA methylation analysis and found that a score of
differentially methylated regions better predicted atopic
disease in children than clinical data [57]. The same
group is currently looking at the correlation of DNA
methylation in the neonates cord blood to better under-
stand the mechanisms involved.
Transgenerational inheritance
It has been well described that through development,
with the shift from pluripotent stem cells to well differ-
entiated specialized cell types, chromatin becomes in-
creasingly repressed by histone modifications and less
activated by permissive histones [58]. However, while it
was originally thought that epigenetic marks were com-
pletely erased from germline upon conception, this con-
cept has been disproved over a decade ago [59,60]. It is
now evident that epigenetic changes induced by environ-
mental exposure may alter the epigenome of the germ-
line and persist through generations.
In their canonical experiment with the agouti mouse
model, Morgan et al., fed mice with a methyl-donor rich
diet that favored the methylation of the agouti gene,
which codes for signalling peptide in mice, which affects
coat colour pigmentation. Not only did this influence
their immediate offspring’s fur color, but throughout five
generations with the exact same diet, the fur coat would
get darker and darker showing transgenerational trans-
mission of the phenotype, which is not only inherited
but augmented [60]. The experiment was repeated re-
cently by Cropley and colleagues who studied the effect of
stopping the methyl donor rich diet after 5 generations
[61]. Interestingly they found that the following generation
(F6), which was not exposed to the diet, actually exhibited
a further increase in fur pigmentation, with normal color
returning only with the second generation off therapy (F7).
Mice from the fifth generation had been weaned and put
on normal control diet before mating, showing the effect
of the diet did not take place in utero. Rather, it suggests
that germ cells exposed to excess methyl donors withinthe developing F5 females retained a memory of the me-
thyl donor effect, manifested in F6 mice [61].
In utero diet supplementation with methyl donors has
similarly been shown to increase allergic disease in a
mouse model [62]. The F1 progeny exposed to an in utero
diet supplemented with methyl donors demonstrated en-
hanced cardinal features of allergic airway disease, includ-
ing airway hyperreactivity, lung lavage eosinophilia and
IL-13, higher concentrations of serum IgE as well as
change in splenocyte phenotype compared to controls on
normal diet. More importantly, these traits were passed
down transgenerationally, although somewhat less ro-
bustly, in F2 “grand-children” mice which did not have in
utero supplementation. In human, transgenerational in-
heritance is exemplified by the effects of tobacco, which
may last for 2 generations. Li et al. compared 338 children
diagnosed with asthma in their first 5 years of life to 570
countermatched controls and found that a child whose
maternal grandmother smoked during pregnancy had
double the chance of developing asthma [63]. This risk
was even greater if the mother also smoked during preg-
nancy (OR = 2.6, compared to 1.8 if she did not) support-
ing the epigenetic transgenerational model in which
persistent exposure leads to inheritance and augmentation
of the phenotype. However, this association was only repli-
cated for paternal grandmother smoking (which had not
been investigated in the former report) in a recent study
[64]. The reason for these discordant results is unclear. It
could relate to differences in study populations. The first
study included children from a southern California cohort
[65] (66% white, relatively high levels of air pollution) with
slightly earlier diagnosis of asthma (before 5 years) while
the second one, from Avon, UK (96% white), included
subjects with diagnosis before 7 years of age.
Transgenerational inheritance of epigenetic traits is ex-
tremely interesting from an epidemiologic point of view as
it provides a new hypothesis for the persistently increasing
prevalence of allergy and related disorders. If the recent
increase had been due to a change in environment, preva-
lence should have increased at once and remained stable
as long as this environment remained the same. However,
if the new environment induces epigenetic changes, a
transgenerational amplification of the atopic phenotype
would be expected even with stable exposure (Figure 5).
Furthermore, according to this hypothesis, it would be ex-
pected that the benefit of some interventions to prevent
allergies (such as pro- and prebiotics) could take a full
generation before reaching their full effect, hence possibly
the somewhat disappointing results so far [66].
Association studies in asthma and allergy
At this stage, most of the epigenetic literature on asthma
and allergy consists of association studies [67-88]. As with
genetic association studies, both candidate gene and
Figure 5 Transgenerational amplification hypothesis. Panel A depicts a purely environmental model for the rise of atopic disease, in which a
change in environment increases baseline genetic risk for the disease. Panel B depicts an epigenetic transgenerational inheritance model, in which a
persistent change in environment does not only increase baseline risk but induces transmittable epigenetic changes leading to amplification of the
phenotype with every subsequent generation. Return to a normal environment, will lead to resolution of the phenotype but only after 2 generations.
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proach has the benefit of allowing the specific study of a
certain number of particularly relevant genes. Its main
disadvantage is the fact that it relies on the investigators
hypothesis as to which gene(s) to study. Genome-wide
approaches do not have this limitation. However, the
amount of analysed data is so great that some relevant
but weakly associated loci may be lost after statistical
corrections.
Figure 6 provides a list of selected loci that have been re-
ported to be associated with allergic phenotypes and/or
environmental risk factors. Association studies are ex-
tremely helpful to provide a description of the epigen-
etic landscape of a given phenotype, which can lead to
the identification of potential biomarkers or targets fortherapy. However, they are not sufficient to conclude
causality, especially when dealing with a mixed cell popu-
lation (biopsy or whole PBMCs). Since different differenti-
ated cell types exhibit a different methylation pattern (i.e.
Th2 vs Th1 vs Treg cells), changes in the proportion of
these subsets will directly affect the methylation pattern of
the overall population. Thus, finding more demethylation
of the Th2 LCR genes (IL-4, IL-13) in PBMCs from atopic
individuals may be only a reflection of the larger pro-
portion of Th2 cells in those individuals, and not the
cause of it.
An exciting aspect of epigenetics is that it sheds a new
light on previous genetic association studies. Since epi-
genetic marks have the potential to silence a gene, it is
to be expected that it can modulate the effect of an
Figure 6 Loci identified from previous DNA methylation association studies for asthma, atopy and related exposures.
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IL-4R single-nucleotide polymorphism (SNP) rs3024685,
which is not associated with asthma on its own, carries a
significant risk for the disease when controlled for IL4-R
methylation [69].
Similarly, the 17q12-21 which carries 2 polymorphisms
associated with maternally inherited risk for asthma was
found to be highly methylated in adult males [89]. In
fact, epigenetic changes can alter the effect of gene poly-
morphisms over time. The decreasing effect of CD14
polymorphism on soluble CD14 levels has been shown
to be paralleled by small but significant increases in
CD14 methylation from 2 to 10 years of age [90].
Genetic polymorphisms can also in turn affect epigenet-
ics regulation of gene expression at a given locus [71,75].
Morales and colleagues showed that hypomethylation of
CpG site in the arachidonate 12-lipoxygenase (ALOX12)
gene correlated with wheezing in two Spanish cohorts. In
both cohorts, they found that the extent of hypomethyla-
tion correlated with the genotype for haplotype-tagging
single nucleotide polymorphism (SNP) rs312466. In the
Menorca cohort for example, subjects with G/G genotype
had a 25% genome methylation at CpG site E85, com-
pared to 15% and 7% methylation for genotypes G/A and
A/A, respectively) [71]. Recently, North and colleagues
found that DNA methylation of the Ephrin-B3 gene
(EFNB3), a transmembrane ligand for receptor tyrosine ki-
nases involved in bidirectional signaling, correlated with
total symptom scores recorded after exposure to grass fortwo days in an Environmental Exposure Unit [91]. They
also identified two SNPs which influenced on methylation
status. One of those, rs3744262 changes a cytosine for a
thymine on a CpG site (CpG-SNP) and therefore directly
impacted on its methylation. These studies show how
polymorphisms and epigenetic regulations are interrelated
and how future studies should be structured to examine
these interactions.
Potential underlying mechanisms
Although our understanding is still superficial, there is
an increasing amount of literature looking into the
mechanisms by which allergic phenotypes and environ-
mental exposures could be associated with specific epi-
genetic changes.
In lung biopsies, the HDAC: HAT ratio has been shown
to be lower in asthmatic samples and to correct with treat-
ment [92-96]. This is significant as endogenous HDAC ac-
tivity may play a crucial role in maintaining the balance of
pre-established Th1-like and Th2-like responses. When
their endogenous HDAC activity is inhibited, ex vivo
memory T cells show an increase in Th2-associated recall
response (IL-13, IL-5) and reduction in Th1- (IFN-γ,
CXCL10) or Tr1-associated (IL-10) recall response, shift-
ing the Th1:Th2 ratios by 3-fold to 8-fold [97]. However,
the relation between HDAC/HAT activity and allergic
inflammation is not that simple. Inhibition HDAC may
also increase the suppressive function of FOXP3+ Tregs
ex vivo [98] and the induction of pTregs by the metabolites
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HDAC inhibitory property which decreases proinflamma-
tory cytokine expression in dendritic cell [99]. The trans-
maternal asthma protection provided by the farm-derived
gram-negative bacterium Acinetobacter lwoffii F78 was as-
sociated with an increase in permissive H4 acetylation of
the INF-γ locus and this protection was abolished when
mice were treated with an HAT inhibitor [100]. It is im-
portant to point out that histones are not the only targets
of acetylation. Multiple cellular proteins with important
functions are also regulated by acetylation and will be af-
fected by changes of HDAC/HAT activities. This includes
signal transducers and nuclear factors that are relevant to
the immune response such as GATA-3 and FOXP3 [101].
More specifically, mice studies have shown that optimal
Treg function requires acetylation of several lysines in the
forkhead domain of Foxp3 which enhance binding to the
Il2 promoter and suppress endogenous IL-2 production
[102,103]. In the end, the question remains as to what
causes this change in HDAC/HATactivity in the first place
in atopic subjects.
Environmental tobacco smoke supresses the expres-
sion and activity of HDAC2 and HDAC3 [104,105]. Ex-
posure to tobacco smoke has also been shown to alter
the expression of dnmt1 and dnmt3b [106]. Both to-
bacco smoke and pollution induce oxidative stress which
are thought to favour the demethylation process, as well
as to cause lesions to DNA which prevent binding of
Dnmt, resulting in a non-specific decrease in methyla-
tion across the genome [107-109]. This non-specific
interference with the epigenetic process could potentially
have a major impact on a concomitant immune response
to an allergen given the complex epigenetic control in-
volved in mounting such a response.
Although a diet rich in methyl-donor nutrients has
been shown to promote DNA methylation and to induce
an allergic phenotype in mice, the same has yet to be
shown for humans [62]. Maternal intake of folic acid (a
methyl donor) during pregnancy does not influence risk
for atopy [110], asthma [111] or food allergy [112].
Whether the previously reported protective effect of
antioxidant supplement can be related to an effect on
DNA demethylation is still undetermined [113-116].
Conclusion
Epigenetics is an exciting new field in allergy and asthma
research that has strongly evolved in the last decade. Re-
cent studies shed a new light on the pathogenesis of this
complex group of disease, not only with regards to gene-
environment interaction but also with regards to the
model of inheritance and its epidemiological implications.
The field is still at its infancy stage and more work needs
to be done to dissect the epigenome of asthma and allergy
and to better understand its underlying mechanisms.Abbreviations
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